Prolactinoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
(Mahshid)
m (Bot: Removing from Primary care)
 
Line 36: Line 36:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}


[[Category:Disease]]
[[Category:Disease]]
Line 42: Line 44:
[[Category:Medicine]]
[[Category:Medicine]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Up-To-Date]]​
[[Category:Up-To-Date]]
[[Category:Primary care]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Neurology]]
[[Category:Neurology]]
[[Category:Neurosurgery]]
[[Category:Neurosurgery]]
[[Category:Endocrinology]]

Latest revision as of 23:49, 29 July 2020

Prolactinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Prolactinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

ECG

X-ray

Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Prolactinoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Prolactinoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Prolactinoma epidemiology and demographics

CDC on Prolactinoma epidemiology and demographics

Prolactinoma epidemiology and demographics in the news

Blogs on Prolactinoma epidemiology and demographics

Directions to Hospitals Treating Prolactinoma

Risk calculators and risk factors for Prolactinoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2], Faizan Sheraz, M.D. [3]

Overview

About 45% of pituitary adenomas are prolactinomas, making it the most common type of all pituitary adenomas. Worldwide, the prevalence of sporadic prolactinoma is 6 to 10 per 100,000 persons. The prevalence of prolactinoma in people less than 20 years old is 10 per 100,000 individuals worldwide. Prolactinoma most commonly affects women in reproductive age group (20 to 50 years). Prolactinoma is more common in females than males in people between 20 and 50 years old. Distribution among males and females becomes similar after age 50.

Epidemiology and Demographics

Prevalence

Incidence

Age

  • Age specific distribution of prolactinoma is as follows:[1][2]
    • Prolactinoma commonly affects individuals between 20 and 50 years old.
    • Prolactinoma occur less commonly in people less than 20 years old, with a prevalence of 10 per 100,000 individuals. These tumors account for less than 2% of intracranial tumors in this age group.

Gender

  • Women usually have microprolactinoma whereas men usually have macroadenoma.[1]
  • Gender-based frequency of prolactinoma depends on the age of the individual:
    • Age group: 20 to 50 years
      • Women are more commonly affected by prolactinoma than men. The female to male ratio is approximately 10:1.[1]
      • Women aged 20 to 30 years have the highest prevalance of prolactinoma, with a female to male ratio of approximately 14:1.
    • Age group: >50 years[2]
      • Men and women are affected equally after age 50 years.
      • The prevalence of prolactinoma increases with age in men after age 50 and peaks during ages 60 to 70 years. At this time, the female to male ratio is 1:3.

References

  1. 1.0 1.1 1.2 1.3 1.4 Ciccarelli A, Daly AF, Beckers A (2005). "The epidemiology of prolactinomas". Pituitary. 8 (1): 3–6. doi:10.1007/s11102-005-5079-0. PMID 16411062.
  2. 2.0 2.1 Mindermann T, Wilson CB (1994). "Age-related and gender-related occurrence of pituitary adenomas". Clin Endocrinol (Oxf). 41 (3): 359–64. PMID 7893282.

Template:WikiDoc Sources